Insider · CIK 0001273306
Simon X Benito
Files at INO (INOVIO PHARMACEUTICALS, INC.). First filing -, latest -.
In brief
Simon X Benito files SEC Form 4 as director at INO (INOVIO PHARMACEUTICALS, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Simon X Benito has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Common Stock Optionsderivative | +41,800 | $0.00 | $0 | 41,800 | May 21, 2026 |
| May 20, 2026 | INO INOVIO PHARMACEUTICALS, INC. | AGrant or award Restricted Stock Unitderivative | +34,200 | $0.00 | $0 | 34,200 | May 21, 2026 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Common Stock | +2,167 | - | - | 12,191 | May 21, 2025 |
| May 21, 2025 | INO INOVIO PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitderivative | -2,167 | $0.00 | $0 | 0 | May 21, 2025 |
Questions about Simon X Benito
Answered from the filings on this page, as of the latest one.
Is Simon X Benito buying or selling?
Simon X Benito has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Simon X Benito's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Simon X Benito has 0.
Where does Simon X Benito file Form 4?
Simon X Benito has filed Form 4 at INO (INOVIO PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.